Literature DB >> 6218794

Abnormal platelet aggregation response in Huntington's disease.

Y Muramatsu, H Kaiya, H Imai, M Nozaki, H Fujimura, M Namba.   

Abstract

Platelet aggregation response to epinephrine, dopamine, serotonin, adenosine diphosphate, arachidonic acid, and collagen was examined in seven patients with Huntington's disease and nine of their relatives. All patients, except for two cases that were in terminal states, showed enhanced response to all the stimulants, especially to dopamine and epinephrine. The platelet aggregation response in many relatives also deviated from the normal limit. The relationship between platelet aggregation abnormality in Huntington's disease and the pathophysiology of the disease was discussed from the view of a generalized membrane defect hypothesis in Huntington's disease, and of disturbed cathecholamine metabolism, both in the CNS and periphery. A possibility that platelet aggregation response examination will be a useful screening test of offspring at risk was proposed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218794     DOI: 10.1007/bf02141780

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  14 in total

1.  Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea.

Authors:  D R McLean; T Nihei
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

Review 2.  Huntington's disease: a generalized membrane defect.

Authors:  D A Butterfield; W R Markesbery
Journal:  Life Sci       Date:  1981-03-09       Impact factor: 5.037

3.  Platelet aggregation, 5-hydroxytryptamine uptake and release in Huntington's chorea.

Authors:  M Diez-Ewald; E Bonilla; J V Gonzalez
Journal:  Prog Neuropsychopharmacol       Date:  1980

4.  Aggregation-induced alterations in human platelet membranes: a spin label study.

Authors:  K Ohki; A Imai; Y Nozawa
Journal:  Biochem Biophys Res Commun       Date:  1980-06-30       Impact factor: 3.575

5.  Uptake of 14C-dopamine in platelets of Huntington's chorea patients and symptom-free offspring.

Authors:  E Bonilla; N Vargas-Urribari; F Navas
Journal:  Lancet       Date:  1978-07-15       Impact factor: 79.321

6.  [Effect of fasting on platelet aggregation in the rabbit and the rat (author's transl)].

Authors:  Y Tanimoto; Y Hattori; S Suzuki
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1980-10

7.  Liberation of catecholamines and 5-hydroxytryptamine from human blood-platelets.

Authors:  M Peyer; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

8.  Platelet monoamine oxidase activity in Huntington's chorea.

Authors:  J Mann; E Chiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

9.  Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.

Authors:  R F Butterworth; M Gonce; A Barbeau
Journal:  Can J Neurol Sci       Date:  1977-11       Impact factor: 2.104

10.  Platelet uptake of serotonin and dopamine in Huntington disease.

Authors:  G S Omenn; L Smith
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

View more
  4 in total

Review 1.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

2.  Platelet-derived extracellular vesicles in Huntington's disease.

Authors:  Hélèna L Denis; Jérôme Lamontagne-Proulx; Isabelle St-Amour; Sarah L Mason; Andreas Weiss; Sylvain Chouinard; Roger A Barker; Eric Boilard; Francesca Cicchetti
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

3.  Platelet abnormalities in Huntington's disease.

Authors:  Hélèna L Denis; Jérôme Lamontagne-Proulx; Isabelle St-Amour; Sarah L Mason; Jesse W Rowley; Nathalie Cloutier; Marie-Ève Tremblay; Antony T Vincent; Peter V Gould; Sylvain Chouinard; Andrew S Weyrich; Matthew T Rondina; Roger A Barker; Eric Boilard; Francesca Cicchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-12-19       Impact factor: 10.154

4.  Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.

Authors:  Albino Carrizzo; Alba Di Pardo; Vittorio Maglione; Antonio Damato; Enrico Amico; Luigi Formisano; Carmine Vecchione; Ferdinando Squitieri
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.